Message
  • EU e-Privacy Directive

    This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.

    View e-Privacy Directive Documents

High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animal

High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors.

 

Abstract

BACKGROUND:

The treatment of human cancer has been seriously hampered for decades by resistance to chemotherapeutic drugs. A very efficient mechanism of tumor resistance to drugs is the proton pumps-mediated acidification of tumor microenvironment. Metronomic chemotherapy has shown efficacy in adjuvant fashion as well as in the treatment of pets with advanced disease. Moreover, we have shown in veterinary clinical settings that pre-treatment with proton-pumps inhibitors (PPI) increases tumor responsiveness to chemotherapeutics. In this study pet with spontaneously occurring cancer have been recruited to be treated by a combination of metronomic chemotherapy and high dose PPIs and their responses have been matched to those of a historical control of ten patients treated with metronomic chemotherapy alone.

METHODS:

Single arm, non randomized phase II open study, with historical control group, evaluating safety and efficacy of the combination of metronomic chemotherapy and alkalization. Twenty-four companion animals (22 dogs and 2 cats) were treated adding to their metronomic chemotherapy protocol the pump inhibitor lansoprazole at high dose, and a water alkalizer. Their responses have been evaluated by clinical and instrumental evaluation and matched to those of the control group.

RESULTS:

The protocol was overall well tolerated, with only two dogs experiencing side effects due to gastric hypochlorhydria consisting with vomiting and or diarrhea. In terms of overall response, in the alkalized cohort, 18 out of 24 had partial or complete responses (75%), two patients had a stable disease and the remaining patients experienced no response or progressive disease. On the other hand, only one patient in the control group experienced a complete response (10%) and three other experienced short lived responses. Median time to terminal event was 34 weeks for the experimental group versus 2 weeks in the controls (p= 0.042).

CONCLUSIONS:

Patient alkalization has shown to be well tolerated and to increase tumor response to metronomic chemotherapy as well the quality of life in pets with advanced cancer. Further studies are warranted to assess the efficacy of this strategy in patients with advanced cancers in companion animals as well as in humans.

Hear this article
Attachments:
Download this file (spugnini JTM 2014.pdf)spugnini JTM 2014.pdf[High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors]1179 Kb
 
Language Selection
English (United Kingdom)Italian - ItalyDeutsch (DE-CH-AT)Español(Spanish Formal International)French (Fr)
Prossimi Eventi
Cena con Erbe Spontanee D'Estate

IL CASALE DEI BUONI SAPORI

in collaborazione con

CASA DELLE ERBE DELLA TUSCIA E DEL MONTE SORATTE

 

 

Mercoledì 28 Giugno 2017

ore 20.00

 

IL CASALE DEI BUONI SAPORI

Statale Nepesina 311, Loc. Colonnetta - NEPI

 

Info e Prenotazioni Alessandro Sgamuffa

0761 571504  -  338 1385912

 

 

Read more...
Support Cybermed

 

Cybermed ADV
Follow us on

Visitors Counter
mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
mod_vvisit_counterToday10915
mod_vvisit_counterYesterday40019
mod_vvisit_counterThis week50934
mod_vvisit_counterLast week248796
mod_vvisit_counterThis month1269682
mod_vvisit_counterLast month2406870
mod_vvisit_counterAll days99195587

We have: 817 guests, 17 bots online
Your IP: 54.198.201.250
 , 
Today: Jun 27, 2017